Skip to main content

Please wait ...

Michael Mithoefer, MD

Michael Mithoefer, MD, clinical assistant professor of psychiatry at the Medical University of South Carolina. In 2009, he completed & published the first FDA approved clinical trial of MDMA assisted psychotherapy for treatment-resistant PTSD, followed by completion of a Phase II trial. He is overseeing a multisite Phase III study of MDMA-assisted psychotherapy in 13 sites around the US (including the Trauma Research Foundation), and another MDMA-assisted psychotherapy multisite study in Europe and Israel.


Speaker Disclosures:
Financial: Dr. Michael Mithoefer has employment relationships with Columbia University, Bassett Healthcare Network, Medical University of South Carolina, and MAPS Public Benefit Corporation. He has an ownership interest in Awakn Life Sciences and serves on the scientific advisory board. Dr. Mithoefer receives a speaking honorarium and recording royalties from PESI, Inc.
Non-financial: Dr. Michael Mithoefer is a fellow of the American Psychiatric Association.

The Evolving Science of the Use of Psychedelic Substances in the Treatment of PTSD

Michael Mithoefer, MD
May 28, 2021
Media Type:
Digital Recording
£49.99 - Standard

Showing 1 to 5 of 6 entries